Pfizer Stock Surges on Strong Quarterly Profit as COVID19 Drug Demand Boosts Revenue
Pfizer Inc. reports strong quarterly profit fueled by its COVID19 drug amid increased market interest from activist investors, keeping PFE stock performance under spotlight.